Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Questcor Pharmaceuticals Inc (QSC) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Questcor Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 891288.
Total stock buying since 2014: $0.
Total stock sales since 2014: $19,234,289.
Total stock option exercises since 2014: $1,132,462.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2014 | 0 | $0 | 212,042 | $19,234,289 | 165,792 | $1,132,462 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2014-08 | 0 | $0 | 50,000 | $4,601,589 | 0 | $0 |
2014-07 | 0 | $0 | 50,000 | $4,723,590 | 50,000 | $347,200 |
2014-06 | 0 | $0 | 59,750 | $5,327,580 | 56,000 | $374,440 |
2014-05 | 0 | $0 | 52,292 | $4,581,530 | 59,792 | $410,822 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-08-13 | Bailey Don M (See Remarks) | Sale | 40,000 | 91.96 | 3,678,240 |
2014-08-11 | Mulroy Michael H. (See Remarks) | Sale | 10,000 | 92.33 | 923,349 |
2014-07-14 | Bailey Don M (See Remarks) | Sale | 40,000 | 95.37 | 3,814,680 |
2014-07-14 | Bailey Don M (See Remarks) | Option Ex | 40,000 | 5.12 | 204,800 |
2014-07-10 | Mulroy Michael H. (See Remarks) | Sale | 10,000 | 90.89 | 908,910 |
2014-07-10 | Mulroy Michael H. (See Remarks) | Option Ex | 10,000 | 14.24 | 142,400 |
2014-06-24 | Young David (Chief Scientific Officer) | Sale | 6,000 | 91.96 | 551,766 |
2014-06-24 | Young David (Chief Scientific Officer) | Option Ex | 6,000 | 4.54 | 27,240 |
2014-06-13 | Bailey Don M (President and CEO) | Sale | 40,000 | 88.82 | 3,552,799 |
2014-06-13 | Bailey Don M (President and CEO) | Option Ex | 40,000 | 5.12 | 204,800 |
2014-06-10 | Mulroy Michael H. (See Remarks) | Sale | 10,000 | 88.57 | 885,740 |
2014-06-10 | Mulroy Michael H. (See Remarks) | Option Ex | 10,000 | 14.24 | 142,400 |
2014-06-02 | Farrell Stephen C (Director) | Sale | 3,750 | 89.94 | 337,275 |
2014-05-19 | Medeiros David Jeffrey (EVP and CTO) | Sale | 2,292 | 89.66 | 205,500 |
2014-05-19 | Medeiros David Jeffrey (EVP and CTO) | Option Ex | 2,292 | 25.01 | 57,322 |
2014-05-14 | Bradsher Neal C | Option Ex | 7,500 | .84 | 6,300 |
2014-05-13 | Bailey Don M (President and CEO) | Sale | 40,000 | 87.40 | 3,496,120 |
2014-05-13 | Bailey Don M (President and CEO) | Option Ex | 40,000 | 5.12 | 204,800 |
2014-05-12 | Mulroy Michael H. (See Remarks) | Sale | 10,000 | 87.99 | 879,910 |
2014-05-12 | Mulroy Michael H. (See Remarks) | Option Ex | 10,000 | 14.24 | 142,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of QSC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Questcor Pharmaceuticals Inc (symbol QSC, CIK number 891288) see the Securities and Exchange Commission (SEC) website.